NCT02539797

Brief Summary

This study will examine the benefits of transcranial direct current stimulation (tDCS), a new tool that is being developed as a safe and non-invasive neurostimulation method, for improving neurocognitive and social cognitive functions in schizophrenia. This procedure is non-invasive and painless and it results in increase or decrease of spontaneous neuronal firing in the brain. Its safety and beneficial effect on cognition has been demonstrated in healthy individuals and several clinical populations. In this pilot study, the investigators will examine the effect of tDCS on cognitive functions in 40 individuals with schizophrenia. Each participant will arrive for three visits, with approximately one week between each visit. During the first visit, participants will be interviewed about their psychiatric symptoms, personal life experiences, and emotional well being by a specially-trained interviewer. On each of the three visits, participants will receive one of three stimulations: a type of tDCS designed to increase neuronal firing, an alternative form of tDCS designed to decrease neuronal firing, and a sham tDCS (stimulation with no current). Immediately following the stimulation, participants will be asked to complete measures of mental abilities, including tests presented on a computer screen and paper-and-pencil tests. During each visit, participants will also undergo a standard measure of brain activity (EEG) while listening to tones. The first visit will last approximately five hours, and the other two visits will last approximately four hours each. The project will take approximately two years to complete.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 3, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

March 7, 2018

Completed
Last Updated

March 7, 2018

Status Verified

February 1, 2018

Enrollment Period

2 years

First QC Date

August 26, 2015

Results QC Date

November 5, 2017

Last Update Submit

February 6, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Cognition on MCCB

    Summary score of the cognitive domains on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB). Four nonsocial neurocognitive tasks were included: speed of processing, working memory, verbal memory, and reasoning/problem solving. Normed T-scores were calculated for each cognitive subdomain, as well as the cognitive composite score consisting of the average across the four subdomains. The T-scores have a mean of 50, with a difference of 10 points from the mean equaling one standard deviation. Higher T-scores are indicative of higher cognition.

    baseline and 20 minutes

  • Change From Baseline in Managing Emotions on MSCEIT

    Total score on the Managing Emotions component of Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) The test consists of 141 items and 8 ability subtests, which assess four components of emotional processing. In this study, only branches 1 and 4 were administered, focusing on the Managing Emotions component. The total score reflects mean performance across the branches. The scores were converted to normed T-scores that have a mean of 50, with a difference of 10 points from the mean equaling one standard deviation. Higher T-scores are indicative of better performance.

    baseline and 20 minutes

Study Arms (3)

tDCS anodal stimulation

EXPERIMENTAL

anodal stimulation

Device: tDCS

tDCS cathodal stimulation

ACTIVE COMPARATOR

cathodal stimulation

Device: tDCS

Sham stimulation

SHAM COMPARATOR

Sham stimulation. Termination of electrical stimulation following 30 seconds

Device: tDCS

Interventions

tDCSDEVICE

comparing anodal, cathodal, and sham tDCS

Sham stimulationtDCS anodal stimulationtDCS cathodal stimulation

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnostic and Statistical Manual of Mental Disorders (DSM)-V Diagnosis of Schizophrenia
  • Must understand spoken English sufficiently to comprehend testing procedures
  • Estimated premorbid intelligence quotient (IQ) \> 70 (based on reading ability)
  • Ongoing care of a Psychiatrist, Psychologist, or other qualified mental health professional

You may not qualify if:

  • Metal in cranium
  • Cardiac lines/pacemaker
  • Medication pump
  • Increased intracranial pressure
  • Lifetime history of serious head injury (LOC \> 1 hr.)
  • Sedatives or Benzodiazepines within 12 hours of testing
  • Clinically significant neurological disease (e.g., seizures)
  • History of mental retardation or developmental disability
  • Alcohol or substance dependence in the last 6 months
  • Alcohol or substance abuse in the last 1 month
  • Change in medication in past 6 weeks
  • Change in in living situation in the last 2 months
  • Inpatient hospitalization in past 3 months
  • Participation in prior studies involving tDCS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Semel Institute for Neuroscience and Human Behavior

Los Angeles, California, 90095, United States

Location

Related Publications (1)

  • Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects. PLoS One. 2018 May 7;13(5):e0197023. doi: 10.1371/journal.pone.0197023. eCollection 2018.

MeSH Terms

Conditions

Schizophrenia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Limitations and Caveats

The present findings employed a single tDCS administration, which may be insufficient to attain potential therapeutic effects. These findings thus add to the growing body of evidence suggesting the need for basic dose-finding studies in tDCS.

Results Point of Contact

Title
Dr. Yuri Rassovsky
Organization
University of California, Los Angeles

Study Officials

  • Yuri Rassovsky, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Research Psychologist

Study Record Dates

First Submitted

August 26, 2015

First Posted

September 3, 2015

Study Start

October 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

March 7, 2018

Results First Posted

March 7, 2018

Record last verified: 2018-02

Locations